[Form 4] UNITEDHEALTH GROUP INC Insider Trading Activity
Wayne S. DeVeydt, Chief Financial Officer of UnitedHealth Group Inc. (UNH), reported a non-derivative acquisition on 09/23/2025 of 66.899 shares of common stock. The filing states these shares represent dividend equivalents paid on outstanding restricted stock units and were recorded at a $0 price because they are dividend-equivalent awards rather than open-market purchases. After the transaction, Mr. DeVeydt beneficially owned 10,591.899 shares. The filing notes the dividend equivalents are subject to the same vesting and forfeiture terms as the underlying restricted stock units.
Wayne S. DeVeydt, Chief Financial Officer di UnitedHealth Group Inc. (UNH), ha riportato un'acquisizione non derivativa il 23/09/2025 di 66.899 azioni ordinarie. La pratica indica che queste azioni rappresentano equivalenti ai dividendi pagati su unità azionarie limitate in sospeso e sono state registrate a un prezzo di 0 $ perché si tratta di premi equivalenti a dividendi anziché acquisti sul mercato aperto. Dopo la transazione, il signor DeVeydt detiene 10.591,899 azioni.
La pratica evidenzia che gli equivalenti al dividendo sono soggetti alle stesse clausole di vesting e di perdita delle unità azionarie limitate sottostanti.
Wayne S. DeVeydt, Director Ejecutivo de Finanzas de UnitedHealth Group Inc. (UNH), comunicó una adquisición no derivativa el 23/09/2025 de 66,899 acciones ordinarias. El informe señala que estas acciones representan equivalentes de dividendos pagados sobre unidades de acciones restringidas en circulación y se registraron a un precio de $0 porque se trata de premios equivalentes a dividendos en lugar de compras en el mercado abierto. Tras la transacción, el Sr. DeVeydt poseía beneficiosamente 10.591,899 acciones.
El documento señala que los equivalentes de dividendos están sujetos a las mismas condiciones de vesting y de pérdida que las unidades restringidas subyacentes.
Wayne S. DeVeydt, UnitedHealth Group Inc. (UNH)의 최고재무책임자(CFO)는 2025/09/23에 66.899 주의 비파생 취득을 보고했습니다. 공시에는 이 주식이 미결제 제한 주식단위에 대해 지급된 배당 수당을 나타내며, 차익실현이 아닌 배당수당 보상으로서 $0의 가격으로 기록되었으므로 시장가 매수가 아님을 명시하고 있습니다. 거래 후 10,591.899 주를 수익적으로 소유하게 되었습니다. 공시는 배당수당이 기초가 되는 제한 주식단위와 같은 귀속 및 몰수 조건의 적용을 받는다고 밝히고 있습니다.
Wayne S. DeVeydt, directeur financier de UnitedHealth Group Inc. (UNH), a déclaré une acquisition non dérivée le 23/09/2025 de 66.899 actions ordinaires. Le dossier indique que ces actions représentent des équivalents de dividende payés sur des unités d’actions restreintes en circulation et ont été enregistrées à un prix de 0 $ car il s’agit d’allocations équivalentes au dividende plutôt que d’achats sur le marché libre. Après la transaction, M. DeVeydt détenait 10.591,899 actions bénéficiellement.
Le dossier note que les équivalents de dividende sont soumis aux mismas conditions de vesting et d’annulation que les unités d’actions restreintes sous-jacentes.
Wayne S. DeVeydt, Chief Financial Officer von UnitedHealth Group Inc. (UNH), meldete am 23.09.2025 eine nicht-derivative Akquisition von 66.899 Stammaktien. Die Einreichung besagt, dass diese Aktien Dividendenäquivalente sind, die auf ausstehende Restricted Stock Units gezahlt werden, und mit einem Preis von 0 $ verbucht wurden, da es sich um Dividendenäquivalente Award handelt, nicht um Käufe am offenen Markt. Nach der Transaktion besaß Herr DeVeydt wirtschaftlich 10.591,899 Aktien. Die Einreichung weist darauf hin, dass die Dividendenäquivalente denselben Vesting- und Wegfallbedingungen wie die zugrunde liegenden Restricted Stock Units unterliegen.
Wayne S. DeVeydt، المدير المالي لشركة UnitedHealth Group Inc. (UNH)، أبلغ عن اكتساب غير مشتق في 23/09/2025 لعدد 66.899 سهم من الأسهم العادية. تُشير الإيداع إلى أن هذه الأسهم تمثل معادلات أرباح مدفوعة على وحدات الأسهم المقيدة القائمة وتُسجَّل بسعر $0 لأنها جوائز معادلة للأرباح وليست شراء في السوق المفتوح. بعد الصفقة، أصبح السيد DeVeydt يمتلك بشكل مستفيد 10.591,899 سهم. وتذكر الإيداع أن معادلات الأرباح تخضع لنفس شروط الاستحقاق وفقدان الملكية مثل وحدات الأسهم المقيدة الأساسية.
Wayne S. DeVeydt，UnitedHealth Group Inc.（UNH）的首席财务官，於 2025/09/23 披露了非衍生品取得，涉及 66,899 股普通股。该披露指出这些股票代表对未归属的受限 Stock Unit（RSU）支付的股息等值，由于这是股息等值奖励而非在公开市场购买，记账价格为 $0。交易完成后，DeVeydt先生实际拥有 10,591,899 股。披露还指出，股息等值受与基础受限股票单位相同的归属和没收条款约束。
- Disclosure compliance: Timely Form 4 filing discloses insider equity activity for the CFO.
- Ownership increased: Reporting person beneficial ownership rose by 66.899 dividend-equivalent shares, recorded transparently.
- Forfeiture risk: The dividend equivalents are subject to the same vesting and forfeiture terms as the underlying restricted stock units, meaning they may be forfeited if RSUs do not vest.
Insights
TL;DR: Routine insider reporting of dividend-equivalent RSU credits; governance implications minimal and standard.
The Form 4 documents a common, non-cash issuance of 66.899 dividend-equivalent shares tied to restricted stock units. Such entries are typically administrative and do not reflect open-market trading or additional compensation beyond existing equity awards. The filing appropriately discloses that the dividend equivalents carry the same vesting and forfeiture conditions as the underlying RSUs, which is standard practice to align executive incentives with shareholder interests.
TL;DR: Small, non-cash equity accrual reported; immaterial to UNH valuation based on the filing alone.
The reported 66.899 shares were recorded at $0 and described as dividend equivalents on outstanding restricted stock units, indicating these are accruals tied to existing awards rather than new compensation or market purchases. The post-transaction beneficial ownership is listed as 10,591.899 shares. The filing provides no information on market value or proportional ownership relative to total outstanding shares, so material impact cannot be assessed from this document alone.
Wayne S. DeVeydt, Chief Financial Officer di UnitedHealth Group Inc. (UNH), ha riportato un'acquisizione non derivativa il 23/09/2025 di 66.899 azioni ordinarie. La pratica indica che queste azioni rappresentano equivalenti ai dividendi pagati su unità azionarie limitate in sospeso e sono state registrate a un prezzo di 0 $ perché si tratta di premi equivalenti a dividendi anziché acquisti sul mercato aperto. Dopo la transazione, il signor DeVeydt detiene 10.591,899 azioni.
La pratica evidenzia che gli equivalenti al dividendo sono soggetti alle stesse clausole di vesting e di perdita delle unità azionarie limitate sottostanti.
Wayne S. DeVeydt, Director Ejecutivo de Finanzas de UnitedHealth Group Inc. (UNH), comunicó una adquisición no derivativa el 23/09/2025 de 66,899 acciones ordinarias. El informe señala que estas acciones representan equivalentes de dividendos pagados sobre unidades de acciones restringidas en circulación y se registraron a un precio de $0 porque se trata de premios equivalentes a dividendos en lugar de compras en el mercado abierto. Tras la transacción, el Sr. DeVeydt poseía beneficiosamente 10.591,899 acciones.
El documento señala que los equivalentes de dividendos están sujetos a las mismas condiciones de vesting y de pérdida que las unidades restringidas subyacentes.
Wayne S. DeVeydt, UnitedHealth Group Inc. (UNH)의 최고재무책임자(CFO)는 2025/09/23에 66.899 주의 비파생 취득을 보고했습니다. 공시에는 이 주식이 미결제 제한 주식단위에 대해 지급된 배당 수당을 나타내며, 차익실현이 아닌 배당수당 보상으로서 $0의 가격으로 기록되었으므로 시장가 매수가 아님을 명시하고 있습니다. 거래 후 10,591.899 주를 수익적으로 소유하게 되었습니다. 공시는 배당수당이 기초가 되는 제한 주식단위와 같은 귀속 및 몰수 조건의 적용을 받는다고 밝히고 있습니다.
Wayne S. DeVeydt, directeur financier de UnitedHealth Group Inc. (UNH), a déclaré une acquisition non dérivée le 23/09/2025 de 66.899 actions ordinaires. Le dossier indique que ces actions représentent des équivalents de dividende payés sur des unités d’actions restreintes en circulation et ont été enregistrées à un prix de 0 $ car il s’agit d’allocations équivalentes au dividende plutôt que d’achats sur le marché libre. Après la transaction, M. DeVeydt détenait 10.591,899 actions bénéficiellement.
Le dossier note que les équivalents de dividende sont soumis aux mismas conditions de vesting et d’annulation que les unités d’actions restreintes sous-jacentes.
Wayne S. DeVeydt, Chief Financial Officer von UnitedHealth Group Inc. (UNH), meldete am 23.09.2025 eine nicht-derivative Akquisition von 66.899 Stammaktien. Die Einreichung besagt, dass diese Aktien Dividendenäquivalente sind, die auf ausstehende Restricted Stock Units gezahlt werden, und mit einem Preis von 0 $ verbucht wurden, da es sich um Dividendenäquivalente Award handelt, nicht um Käufe am offenen Markt. Nach der Transaktion besaß Herr DeVeydt wirtschaftlich 10.591,899 Aktien. Die Einreichung weist darauf hin, dass die Dividendenäquivalente denselben Vesting- und Wegfallbedingungen wie die zugrunde liegenden Restricted Stock Units unterliegen.
FAQ
What did UNH CFO Wayne S. DeVeydt report on Form 4?
Are the shares purchased by UNH CFO a cash purchase?
How many UNH shares does the reporting person own after the transaction?
Do the dividend-equivalent shares reported for UNH have any restrictions?
When was the Form 4 signed and who signed it?
